Literature DB >> 7794785

A behavioral link between the oculomotor and cardiovascular systems.

R A Tyrrell1, J F Thayer, B H Friedman, H W Leibowitz, E L Francis.   

Abstract

Although the eyes and the heart serve very different purposes, each receives autonomic innervation. Capitalizing on recent theoretical and technological innovations in the understanding and assessment of oculomotor and cardiovascular behavior, three experiments measured behavioral covariation between the oculomotor and cardiovascular systems. Measures of dark focus and dark vergence indexed oculomotor tone, and the spectral decomposition of variations in heart rate indexed cardiovascular control mechanisms. In Experiment 1, individual differences in cardiovascular parameters could predict individuals' dark vergence (R2 = .806) but not their dark focus (R2 = .404). In Experiment 2, the same parameters were measured from subjects who experience either panic attacks (n = 11) or blood phobia (n = 9). Heart rate was positively correlated with dark vergence and the two subject groups were separable based on both oculomotor and cardiovascular variables. Using a within-subjects approach, Experiment 3 found that both dark vergence and dark focus tended to be nearer during sympathetic dominance of the heart than during parasympathetic dominance, within-subjects variations in cardiovascular parameters could predict dark focus, and between-subjects variations in interbeat intervals could predict dark vergence. Shared patterns of autonomic activation may be responsible for this eye-heart link.

Entities:  

Mesh:

Year:  1995        PMID: 7794785     DOI: 10.1007/bf02691389

Source DB:  PubMed          Journal:  Integr Physiol Behav Sci        ISSN: 1053-881X


  46 in total

1.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

2.  Correction of empty-field myopia on the basis of the dark-focus of accommodation.

Authors:  R B Post; R L Owens; D A Owens; H W Leibowitz
Journal:  J Opt Soc Am       Date:  1979-01

Review 3.  Accommodation function of the human eye.

Authors:  F M Toates
Journal:  Physiol Rev       Date:  1972-10       Impact factor: 37.312

4.  The effects of sympathetic stimulation and epinephrine on the superior rectus muscle of the cat.

Authors:  K E Eakins; R L Katz
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

5.  Near work, visual fatigue, and variations of oculomotor tonus.

Authors:  D A Owens; K Wolf-Kelly
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-04       Impact factor: 4.799

Review 6.  Ocular accommodation, personality, and autonomic balance.

Authors:  V J Gawron
Journal:  Am J Optom Physiol Opt       Date:  1983-07

7.  Clinical evaluation of the Canon Autoref R-1.

Authors:  N A McBrien; M Millodot
Journal:  Am J Optom Physiol Opt       Date:  1985-11

8.  The relation of vergence effort to reports of visual fatigue following prolonged near work.

Authors:  R A Tyrrell; H W Leibowitz
Journal:  Hum Factors       Date:  1990-06       Impact factor: 2.888

9.  The effect of Timolol Maleate on tonic accommodation, tonic vergence, and pupil diameter.

Authors:  B Gilmartin; R E Hogan; S M Thompson
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-06       Impact factor: 4.799

10.  Panic disorder: cognitive-behavioral treatment.

Authors:  L Michelson; K Marchione; M Greenwald; L Glanz; S Testa; N Marchione
Journal:  Behav Res Ther       Date:  1990
View more
  2 in total

1.  Significance of autonomic nervous system activity in functional dyspepsia.

Authors:  E R Muth; K L Koch; R M Stern
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Effect of unilateral forced nostril breathing on tonic accommodation and intraocular pressure.

Authors:  Jennifer C Chen; Brian Brown; Katrina L Schmid
Journal:  Clin Auton Res       Date:  2004-12       Impact factor: 4.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.